Skip to main content

Page last checked

Goal

Peptides for anxiety and depression

Selank is the only peptide on this site with published human anxiety studies. None of those abstracts states how much participants received.

Source for this answer

Source: Based on 2 compound guides · checked 2026-09-07

Source: Based on 2 compound guides · checked 2026-09-07

The available Selank abstracts report anxiety outcomes but omit the amount given. They support a discussion of the studies, not a dosing schedule.

Semax studies cited here focused on brain and nerve conditions. BPC-157’s small human reports covered other problems. None provides a direct comparison of these three as treatments for depression.

At a glance

Compounds covered

2

FDA-approved for this goal

0

Being tested for this goal

0

Reported use only

1

Start with the outcome

Which mental-health question are you trying to answer?

Anxiety treatment, depression, peptide comparisons and GLP-1 safety are different questions. Choose the one that matches what you want to know.

Small human comparisons exist

Selank for anxiety

Russian groups compared Selank with older sedatives in people with anxiety disorders. The available study summaries report anxiety outcomes but omit the dose.

Open the Selank evidence guide

No peptide ranks first

The best medicine for anxiety

These peptide records do not show a best anxiety treatment. If the question began after a GLP-1, that is a separate class-safety question with its own FDA timeline.

Read the separate GLP-1 safety evidence

No depression comparison

Semax or Selank for depression

The cited studies do not compare the two as depression treatments. Selank’s human papers studied anxiety disorders; Semax’s human papers studied stroke recovery and motor-neuron disease.

See what Semax was actually studied for

No human anxiety study

BPC-157 for anxiety

BPC-157’s small human reports covered knee pain, bladder symptoms and an infusion safety pilot. None measured anxiety or depression.

Open the BPC-157 human evidence

Two compounds, and what the human studies actually measured

Selank has studies in anxiety. Semax has more human studies, but in different brain and nerve conditions. Neither supports a depression comparison.

◆ 2 compounds coveredsources shown in each row
Compounds people take for this purpose, why they use them, what human research has measured, and where the evidence comes from.
CompoundWhat people take it forWhat research showsEvidence
SelankPeople buy it for anxiety, stress and calm focus, often as a nasal product and sometimes as powder for injection.Measured in a human studyRussian studies reported anxiety outcomes in small groups, including comparisons with medazepam or phenazepam. The available study summaries omit the dose. Some describe tolerability, but they do not show a complete safety profile.limited human dataNo human dose published
SemaxPeople buy it as a nootropic for focus and memory, then compare it with Selank when searching for mood or depression support.Reported use onlyIts human papers studied recovery after stroke, motor-neuron disease and brain injury from a lack of oxygen. None measured anxiety or depression. The clearest result was negative in 27 people with motor-neuron disease, and the published quantities belong to nasal use rather than an injection under the skin.limited human dataDose from a human trial · no FDA label

1 rests on a human study that measured something in this goal. 1 rests on reported use alone, with no study behind it.

The Selank abstracts report outcomes but omit the dose

One study compared Selank and medazepam in 62 people with anxiety-related diagnoses. Another compared Selank and phenazepam in 60 people. A 70-person study tested adding Selank to phenazepam.

The study summaries do not say how much Selank each person took. A reported result cannot supply the missing dose or treatment protocol.

Some study summaries also describe side effects when the drugs were used together. Small comparisons cannot show a full picture of long-term safety.

These studies do not show a depression comparison

The cited papers do not compare Semax with Selank as treatments for depression. They studied different groups and asked different questions.

BPC-157’s small human reports do not show a treatment for anxiety or depression. The evidence here cannot rank these compounds against one another for those conditions.

Where to go next

Every purpose covered this way is listed on the index of goals people buy peptides for.

Questions readers ask

Does Selank work for anxiety?

Small Russian studies compared Selank with older sedatives and reported anxiety outcomes. None of the reachable abstracts states the amount participants received.

What is the best medicine for anxiety?

These peptide records cannot answer that. They do not compare ordinary anxiety treatments, and the Selank evidence is too thin to establish a best option.

Is Semax or Selank better for depression?

The cited studies do not compare them as depression treatments. Selank papers studied anxiety-related disorders, while Semax papers focused on neurologic conditions.

Is BPC-157 good for anxiety?

The small human BPC-157 reports cited here did not study anxiety treatment. They do not establish that it helps anxiety or depression.

8primary sources, each with the day we read it — open the documents used on this page